These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

342 related articles for article (PubMed ID: 15312879)

  • 1. Effects of pravastatin on progression of glucose intolerance and cardiovascular remodeling in a type II diabetes model.
    Yu Y; Ohmori K; Chen Y; Sato C; Kiyomoto H; Shinomiya K; Takeuchi H; Mizushige K; Kohno M
    J Am Coll Cardiol; 2004 Aug; 44(4):904-13. PubMed ID: 15312879
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of combined olmesartan and pravastatin on glucose intolerance and cardiovascular remodeling in a metabolic-syndrome model.
    Mizukawa M; Ohmori K; Obayashi A; Ishihara Y; Yoshida J; Noma T; Yukiiri K; Kosaka H; Kohno M
    Hypertens Res; 2009 Jul; 32(7):617-24. PubMed ID: 19461650
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Left-ventricular diastolic dysfunction may be prevented by chronic treatment with PPAR-alpha or -gamma agonists in a type 2 diabetic animal model.
    Kim SK; Zhao ZS; Lee YJ; Lee KE; Kang SM; Choi D; Lim SK; Chung N; Lee HC; Cha BS
    Diabetes Metab Res Rev; 2003; 19(6):487-93. PubMed ID: 14648808
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adrenocortical insufficiency in Otsuka Long-Evans Tokushima Fatty rats, a type 2 diabetes mellitus model.
    Noguchi S; Ohno Y; Aoki N
    Metabolism; 2007 Oct; 56(10):1326-33. PubMed ID: 17884440
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reversal of elevated cardiac expression of TGFbeta1 and endothelin-1 in OLETF diabetic rats by long-acting calcium antagonist.
    Jesmin S; Zaedi S; Maeda S; Mowa CN; Sakuma I; Miyauchi T
    Exp Biol Med (Maywood); 2006 Jun; 231(6):907-12. PubMed ID: 16741022
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential impact of atorvastatin vs pravastatin on progressive insulin resistance and left ventricular diastolic dysfunction in a rat model of type II diabetes.
    Chen Y; Ohmori K; Mizukawa M; Yoshida J; Zeng Y; Zhang L; Shinomiya K; Kosaka H; Kohno M
    Circ J; 2007 Jan; 71(1):144-52. PubMed ID: 17186993
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vascular proliferation and transforming growth factor-beta expression in pre- and early stage of diabetes mellitus in Otsuka Long-Evans Tokushima fatty rats.
    Hosomi N; Noma T; Ohyama H; Takahashi T; Kohno M
    Atherosclerosis; 2002 May; 162(1):69-76. PubMed ID: 11947899
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activity of the Chinese prescription Hachimi-jio-gan against renal damage in the Otsuka Long-Evans Tokushima fatty rat: a model of human type 2 diabetes mellitus.
    Yamabe N; Yokozawa T
    J Pharm Pharmacol; 2006 Apr; 58(4):535-45. PubMed ID: 16597372
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-acting calcium channel blocker benidipine suppresses expression of angiogenic growth factors and prevents cardiac remodelling in a Type II diabetic rat model.
    Jesmin S; Sakuma I; Hattori Y; Fujii S; Kitabatake A
    Diabetologia; 2002 Mar; 45(3):402-15. PubMed ID: 11914746
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mizoribine reduces renal injury and macrophage infiltration in non-insulin-dependent diabetic rats.
    Kikuchi Y; Imakiire T; Yamada M; Saigusa T; Hyodo T; Hyodo N; Suzuki S; Miura S
    Nephrol Dial Transplant; 2005 Aug; 20(8):1573-81. PubMed ID: 15905195
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of TGF-beta1 in the development of pancreatic fibrosis in Otsuka Long-Evans Tokushima Fatty rats.
    Yoshikawa H; Kihara Y; Taguchi M; Yamaguchi T; Nakamura H; Otsuki M
    Am J Physiol Gastrointest Liver Physiol; 2002 Mar; 282(3):G549-58. PubMed ID: 11842006
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Keishibukuryogan ameliorates glucose intolerance and hyperlipidemia in Otsuka Long-Evans Tokushima Fatty (OLETF) rats.
    Nakagawa T; Goto H; Hussein G; Hikiami H; Shibahara N; Shimada Y
    Diabetes Res Clin Pract; 2008 Apr; 80(1):40-7. PubMed ID: 18242756
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Olmesartan ameliorates a dietary rat model of non-alcoholic steatohepatitis through its pleiotropic effects.
    Kurita S; Takamura T; Ota T; Matsuzawa-Nagata N; Kita Y; Uno M; Nabemoto S; Ishikura K; Misu H; Ando H; Zen Y; Nakanuma Y; Kaneko S
    Eur J Pharmacol; 2008 Jul; 588(2-3):316-24. PubMed ID: 18501344
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ferulic acid prevents pathological and functional abnormalities of the kidney in Otsuka Long-Evans Tokushima Fatty diabetic rats.
    Fujita A; Sasaki H; Doi A; Okamoto K; Matsuno S; Furuta H; Nishi M; Nakao T; Tsuno T; Taniguchi H; Nanjo K
    Diabetes Res Clin Pract; 2008 Jan; 79(1):11-7. PubMed ID: 17897750
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanisms underlying the impaired EDHF-type relaxation response in mesenteric arteries from Otsuka Long-Evans Tokushima Fatty (OLETF) rats.
    Matsumoto T; Kobayashi T; Kamata K
    Eur J Pharmacol; 2006 May; 538(1-3):132-40. PubMed ID: 16678154
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Abnormal renal structural alterations during the development of diabetes mellitus in Otsuka Long-Evans Tokushima Fatty rats.
    Koike T; Tomoda F; Kinuno H; Inoue H; Takata M
    Acta Physiol Scand; 2005 May; 184(1):73-81. PubMed ID: 15847646
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insulin resistance accelerates a dietary rat model of nonalcoholic steatohepatitis.
    Ota T; Takamura T; Kurita S; Matsuzawa N; Kita Y; Uno M; Akahori H; Misu H; Sakurai M; Zen Y; Nakanuma Y; Kaneko S
    Gastroenterology; 2007 Jan; 132(1):282-93. PubMed ID: 17241878
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protective effect of Hachimi-jio-gan against the development of pancreatic fibrosis and oxidative damage in Otsuka Long-Evans Tokushima Fatty rats.
    Yamabe N; Yokozawa T
    J Ethnopharmacol; 2007 Aug; 113(1):91-9. PubMed ID: 17606344
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biochemical and morphological changes during development of sugar cataract in Otsuka Long-Evans Tokushima fatty (OLETF) rat.
    Kubo E; Maekawa K; Tanimoto T; Fujisawa S; Akagi Y
    Exp Eye Res; 2001 Sep; 73(3):375-81. PubMed ID: 11520112
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ramipril treatment suppresses islet fibrosis in Otsuka Long-Evans Tokushima fatty rats.
    Ko SH; Kwon HS; Kim SR; Moon SD; Ahn YB; Song KH; Son HS; Cha BY; Lee KW; Son HY; Kang SK; Park CG; Lee IK; Yoon KH
    Biochem Biophys Res Commun; 2004 Mar; 316(1):114-22. PubMed ID: 15003519
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.